ARMP / Armata Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Armata Pharmaceuticals, Inc.
US ˙ NYSEAM ˙ US04216R1023

Saham Diterbitkan 36,229,842 shares
Saham Orang Dalam47,572,256 shares
Jumlah Orang Dalam43
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mendapati syarikat dibeli oleh orang dalam korporat.

Ia adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat dengan tahap pengumpulan orang dalam yang paling tinggi. Model pemarkahan menggunakan gabungan bilangan bersih orang dalam yang membeli 90 hari sebelumnya, jumlah saham yang dibeli sebagai peratusan saham beredar, dan jumlah saham yang dimiliki oleh orang dalam. Nombor ini berjulat dari 0 hingga 100, dengan nombor yang lebih tinggi menunjukkan tahap pengumpulan yang lebih tinggi kepada rakannya, dan 50 adalah purata.

Kekerapan Kemas Kini: Harian

Lihat Pilihan Teratas Orang Dalam, yang menyediakan senarai syarikat dengan pengumpulan orang dalam tertinggi.

Skor Sentimen Pegawai

Skor Sentimen Pegawai mendapati syarikat dibeli oleh Pegawai Korporat.

Mengikut definisi Pegawai Korporat ialah Orang Dalam Korporat, tetapi tidak seperti beberapa Orang Dalam yang lain (10% Pemegang Saham dan Ahli Lembaga), Pegawai bekerja untuk syarikat tersebut setiap hari, dan mereka menggunakan wang mereka sendiri semasa berdagang . (10% Pemegang Saham dan Ahli Lembaga Pengarah selalunya pengurus dana yang menguruskan wang orang lain.) Oleh itu, dagangan orang dalam yang dibuat oleh Pegawai adalah lebih penting dan harus dilayan dengan sewajarnya.

Seperti Skor Sentimen Orang Dalam, Skor Sentimen Pegawai adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat yang mempunyai tahap pengumpulan pegawai tertinggi.

Kekerapan Kemas Kini: Harian

Lihat Pilihan Teratas Orang Dalam, yang menyediakan senarai syarikat yang mempunyai sentimen orang dalam tertinggi.

Metrik Orang Dalam Utama

Kad ini menunjukkan bagaimana kedudukan syarikat mengikut pelbagai metrik orang dalam. Kedudukan persentil menunjukkan cara syarikat ini dibandingkan dengan syarikat lain di pasaran AS. Kedudukan yang lebih tinggi menunjukkan keadaan yang lebih baik.

Sebagai contoh, adalah diterima umum bahawa pembelian orang dalam ialah penunjuk positif, jadi syarikat yang mempunyai lebih banyak pembelian orang dalam akan mendapat kedudukan lebih tinggi daripada syarikat yang kurang pembelian orang dalam (atau malah jualan orang dalam).

Bilangan Bersih Pembelian Orang Dalam (Kedudukan)

0 ( )

6465 out of 11305

Bilangan Bersih Pembelian Orang Dalam ialah jumlah bilangan orang dalam yang membeli tolak jumlah orang dalam yang menjual dalam tempoh 90 hari terakhir. Kedudukan persentil ditunjukkan di sini (julat dari 0 hingga 100%).

Peratusan Saham Beredar yang Dibeli oleh Orang Dalam (Kedudukan)

0.000 %( )

6390 out of 11224

Peratusan Saham Beredar yang Dibeli oleh Orang Dalam ialah jumlah bilangan saham yang dibeli oleh orang dalam tolak jumlah bilangan saham yang dijual oleh orang dalam dalam tempoh 90 hari terakhir, dibahagikan dengan jumlah saham beredar dan didarab dengan 100.

Carta Dagangan Dalaman

Armata Pharmaceuticals, Inc. dagangan dalaman ditunjukkan dalam carta berikut. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Secara umumnya adalah menyalahi undang-undang bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat material dan bukan awam. Ini tidak bermakna haram untuk mereka membuat sebarang perdagangan dalam syarikat mereka sendiri. Walau bagaimanapun, mereka mesti melaporkan semua dagangan kepada SEC melalui Borang 4.

Senarai Orang Dalam dan Metrik Keberuntungan

Jadual ini menunjukkan senarai orang dalam yang diketahui dan dijana secara automatik daripada pemfailan yang didedahkan kepada SEC. Sebagai tambahan kepada nama, gelaran terkini dan pengarah, pegawai, atau 10% jawatan pemilik, kami menyediakan pegangan yang didedahkan terkini. Selain itu, apabila boleh, kami menyediakan sejarah prestasi perdagangan untuk orang dalam. Sejarah prestasi perdagangan ialah purata wajaran prestasi transaksi pembelian pasaran terbuka sebenar yang dibuat oleh orang dalam. Untuk mendapatkan maklumat lanjut tentang cara ini dikira, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang dalam Purata Keuntungan (%) Saham
Dimiliki
Berpecah
Dilaraskan
Richard Bastiani Director - [D] 27,778 27,778
Igor Bilinsky Chief Operating Officer - [O] 0 0
Biogen Idec Ma Inc 10% Owner - [10%] 11,926,948 11,926,948
Biogen Inc. 10% Owner - [10%] 11,926,948 11,926,948
Jack L Bowman Director - [D] 10,500 10,500
Richard Bear 27,383
Deborah Birx Chief Executive Officer, Director - [D] [O] 217,377 217,377
Barrie J Phd Carter Executive Vice President - [O] 48,766 48,766
Jeremy Curnock Cook Director - [D] 411,105 411,105
Joseph Md Phd Davie Director - [D] 11,000 11,000
Louis Drapeau Director - [D] 10,000 10,000
Delta Dental Plan of Michigan, Inc. 10% Owner - [10%] 2,531,604 2,531,604
Delta Dental of Wisconsin, Inc. 10% Owner - [10%] 2,586,356 2,586,356
Corp Plc Elan 10% Owner - [10%] 11,626,282 11,626,282
Orang dalam Purata Keuntungan (%) Saham
Dimiliki
Berpecah
Dilaraskan
Elan International Services Ltd 10% Owner - [10%] 11,626,282 11,626,282
Paul C Grint Chief Executive Officer, Director - [D] [O] 599 599
Roger Hawley Director - [D] 10,000 10,000
Jules Haimovitz 33,000
Corp Intrexon 10% Owner - [10%] 674,169 674,169
Innoviva Strategic Opportunities LLC Director, 10% Owner - [D] [10%] 16,365,969 16,365,969
Innoviva, Inc. Director, 10% Owner - [D] [10%] 16,365,969 16,365,969
Johnson Wendy S. Interim Chief Operating Office, Director - [D] [O] 1,000 1,000
Randal J Kirk 10% Owner - [10%] 674,169 674,169
Kirk Julian P. 16,200
Odysseas D Kostas 33,000
Robin Kramer 33,000
Pierre Kyme Chief Business Officer - [O] 10,491 10,491
Nelson L Levy Director - [D] 10,070 10,070
Orang dalam Purata Keuntungan (%) Saham
Dimiliki
Berpecah
Dilaraskan
Steven Robert Martin Chief Financial Officer - [O] 3,760 3,760
Duane Alfred Morris VP of Operations - [O] 52,288 52,288
H Stewart Parker Director - [D] 27,778 27,778
Joseph M Patti 33,000
Michael S Perry Director - [D] 411,105 411,105
Todd Patrick Chief Executive Officer, Director - [D] [O] 408,172 408,172
Peterson Todd C. 33,000
David J Poston CFO & VP Finance - [O] 36,700 36,700
Holding Co Renaissance 10% Owner - [10%] 2,531,604 2,531,604
BG Susan Robinson President and CEO - [O] 66,915 66,915
Richard Rychlik Corporate Controller and PFO - [O] 10,000 10,000
Vijay B Samant 10,900
Michael Scott Salka Chief Executive Officer, Director - [D] [O] 11,200 11,200
Schlesinger Sarah J. 33,000
Brian Varnum President and CDO - [O] 64,324 64,324

Report errors via our new Insider Auditing Tool

Rekod Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ARMP / Armata Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Orang dalam Dilaporkan
Saham
Dilaporkan
harga
Dilaraskan
Saham
Dilaraskan
harga
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
2022-03-31 Innoviva, Inc. 5,385,208 5.0000 5,385,208 5.0000 26,926,040 4 5.4000 2,154,083 8.00
2022-02-09 Innoviva, Inc. 3,614,792 5.0000 3,614,792 5.0000 18,073,960
2021-10-29 Innoviva, Inc. 1,212,122 3.3000 1,212,122 3.3000 4,000,003
2021-03-17 Innoviva, Inc. 4,285,935 3.2500 4,285,935 3.2500 13,929,289
2021-01-26 Innoviva, Inc. 1,867,912 3.2500 1,867,912 3.2500 6,070,714

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Rekod Jejak Jualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ARMP / Armata Pharmaceuticals, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Orang dalam Dilaporkan
Saham
Dilaporkan
harga
Dilaraskan
Saham
Dilaraskan
harga
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
2016-12-29 KIRK RANDAL J 20,077 0.4500 20,077 0.4500 9,035 112
2016-12-29 KIRK RANDAL J 21,923 0.4500 21,923 0.4500 9,865
2016-12-28 KIRK RANDAL J 40,450 0.4700 40,450 0.4700 19,012
2016-12-28 KIRK RANDAL J 44,170 0.4700 44,170 0.4700 20,760
2016-12-27 KIRK RANDAL J 24,092 0.5100 24,092 0.5100 12,287
2016-12-27 KIRK RANDAL J 26,308 0.5100 26,308 0.5100 13,417
2005-07-26 BIOGEN INC. 2,500 0.8700 101 21.4600 2,175
2005-07-26 BIOGEN INC. 25,660 0.8600 1,040 21.2133 22,068
2005-07-26 BIOGEN INC. 11,200 0.8500 454 20.9667 9,520

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.

ARMP / Armata Pharmaceuticals, Inc. Insider Trades
Sejarah Transaksi

Klik ikon pautan untuk melihat sejarah transaksi penuh. Transaksi yang dilaporkan sebagai sebahagian daripada pelan dagangan automatik 10b5-1 akan mempunyai X dalam lajur bertanda 10b-5.

Fail
Tarikh
Dagangan
Tarikh
Borang Orang dalam Simbol Saham Nama Sekuriti Kod 10b5-1 Langsung Harga
Pelaksanaan
Harga
Unit
Unit
Berubah
Nilai
Berubah (1K)
Baki
Opsyen
Baki
Saham
2025-07-14 2025-07-10 4 Birx Deborah ARMP Common Stock F - Taxes D 2.2700 -13,637 -31 217,377
2025-04-25 2025-03-14 4 Kyme Pierre ARMP Common Stock F - Taxes D 1.9500 -1,027 -2 10,491
2025-04-25 2025-03-14 4 Birx Deborah ARMP Common Stock F - Taxes D 1.9500 -6,061 -12 231,014
2025-04-25 2024-07-10 4 Birx Deborah ARMP Common Stock F - Taxes D 2.6800 -22,925 -61 237,075
2025-04-25 3/A Kyme Pierre ARMP Common Stock D 1,518
2024-06-28 3 Kyme Pierre ARMP Common Stock D 10,000
2024-03-18 2024-03-14 4 Rychlik Richard ARMP Common Stock A - Award D 10,000 10,000
2024-03-18 2024-03-14 4 Birx Deborah ARMP Common Stock A - Award D 60,000 260,000
2023-12-26 2023-12-21 4 Birx Deborah ARMP Common Stock A - Award D 200,000 200,000
2022-04-15 2022-04-13 4 Peterson Todd C. ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Schlesinger Sarah J. ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Patrick Todd ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Kramer Robin ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Kostas Odysseas D ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 PATTI JOSEPH M ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Morris Duane Alfred ARMP Stock Options (Right to Buy) A - Award D 5.11 41,000 41,000
2022-04-15 2022-04-13 4 Haimovitz Jules ARMP Stock Options (Right to Buy) A - Award D 5.11 33,000 33,000
2022-04-15 2022-04-13 4 Varnum Brian ARMP Stock Options (Right to Buy) A - Award D 5.11 240,000 240,000
2022-04-01 2022-03-31 4 Innoviva, Inc. See footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 5.00 5.0000 0 0 2,692,604
2022-04-01 2022-03-31 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 5.0000 5,385,208 26,926 16,365,969
2022-02-11 2022-02-09 4 Innoviva, Inc. See footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 5.00 5.0000 1,807,396 9,037 1,807,396
2022-02-11 2022-02-09 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 5.0000 3,614,792 18,074 10,980,761
2021-11-01 2021-10-29 4 Innoviva, Inc. See footnotes ARMP Common Stock P - Purchase I 3.3000 1,212,122 4,000 7,365,969
2021-08-03 2021-08-02 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3.82 125,000 125,000
2021-06-09 2021-06-07 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 Kramer Robin ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-06-09 2021-06-07 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 4.29 28,000 28,000
2021-04-05 2021-04-01 4 Haimovitz Jules ARMP Stock Option (Right to Buy) A - Award D 4.74 30,000 30,000
2021-03-26 2021-03-25 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 5.14 112,000 112,000
2021-03-26 2021-03-25 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 5.14 28,000 28,000
2021-03-26 2021-03-25 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 5.14 112,000 112,000
2021-03-26 2021-03-25 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 5.14 56,000 56,000
2021-03-17 2021-03-17 4 Innoviva, Inc. See Footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 3.25 3.2500 4,285,935 13,929 6,153,847
2021-03-17 2021-03-17 4 Innoviva, Inc. See Footnotes ARMP Common Stock P - Purchase I 3.2500 4,285,935 13,929 6,153,847
2021-01-28 2021-01-26 4 Innoviva, Inc. See Footnotes ARMP Warrants to Purchase Common Stock P - Purchase I 3.25 3.2500 1,867,912 6,071 1,867,912
2021-01-28 2021-01-26 4 Innoviva, Inc. See Footnotes ARMP Common Stock P - Purchase I 3.2500 1,867,912 6,071 1,867,912
2020-12-09 2020-12-08 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 BASTIANI RICHARD ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 3.15 23,000 23,000
2020-12-09 2020-12-08 4 Kramer Robin ARMP Stock Option (Right to Buy) A - Award D 3.15 30,000 30,000
2020-03-31 2020-03-27 4 Innoviva, Inc. ARMP Warrants to Acquire Common Stock P - Purchase D 2.87 2.8700 7,717,661 22,150 8,710,800
2020-03-31 2020-03-27 4 Innoviva, Inc. ARMP Common Stock P - Purchase D 2.8700 7,717,661 22,150 8,710,800
2020-02-14 2019-05-09 5 PERRY MICHAEL S ARMP Warrant to Purchase Common Stock J - Other I 0.32 12,065.4600 -46,666 -563,047 0
2020-02-14 2019-05-09 5 COOK JEREMY CURNOCK ARMP Warrant to Purchase Common Stock J - Other I 0.32 12,065.4600 -46,666 -563,047 0
2020-02-14 2020-02-12 4 Kostas Odysseas D ARMP Stock Option (Right to Buy) A - Award D 4.17 27,383 27,383
2020-02-14 2020-02-12 4 Schlesinger Sarah J. ARMP Stock Option (Right to Buy) A - Award D 4.17 27,383 27,383
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1,986,278
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1,986,278
2020-02-14 3 Innoviva, Inc. ARMP Common Stock D 1,986,278
2019-10-15 2019-10-10 4 Peterson Todd C. ARMP Stock Option (Right to Buy) A - Award D 3.77 27,383 27,383
2019-05-24 2019-05-22 4 BASTIANI RICHARD ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 COOK JEREMY CURNOCK ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 PARKER H STEWART ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 PERRY MICHAEL S ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 PATTI JOSEPH M ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 Martin Steven Robert ARMP Stock Option (Right to Buy) A - Award D 3.15 149,362 149,362
2019-05-24 2019-05-22 4 Bear Richard ARMP Stock Option (Right to Buy) A - Award D 3.15 27,383 27,383
2019-05-24 2019-05-22 4 Patrick Todd ARMP Stock Option (Right to Buy) A - Award D 3.15 298,724 298,724
2019-05-24 2019-05-22 4 Morris Duane Alfred ARMP Stock Option (Right to Buy) A - Award D 3.15 74,681 74,681
2019-05-24 2019-05-22 4 Varnum Brian ARMP Stock Option (Right to Buy) A - Award D 3.15 298,724 298,724
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3,736,669
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2,586,356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3,736,669
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2,586,356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock I 2,586,356
2019-05-20 3 Delta Dental of Wisconsin, Inc. ARMP Common Stock D 3,736,669
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-17 3 Renaissance Holding Co ARMP Common Stock I 2,531,604
2019-05-16 3 Varnum Brian ARMP Common Stock D 64,324
2019-05-16 3 Varnum Brian ARMP Common Stock D 64,324
2019-05-16 3 Varnum Brian ARMP Common Stock D 64,324
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52,288
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52,288
2019-05-16 3 Morris Duane Alfred ARMP Common Stock D 52,288
2019-05-16 3 Patrick Todd ARMP Common Stock D 408,172
2019-05-16 3 Patrick Todd ARMP Common Stock D 408,172
2019-05-16 3 Patrick Todd ARMP Common Stock D 408,172
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27,778
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27,778
2019-05-16 3 PARKER H STEWART ARMP Common Stock D 27,778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27,778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27,778
2019-05-16 3 BASTIANI RICHARD ARMP Common Stock D 27,778
2018-03-26 2018-03-22 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 1.1000 181,820 200 411,105
2018-03-26 2017-09-19 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 105,015 229,285
2018-03-26 2017-06-29 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 5,757 124,270
2018-03-26 2016-11-22 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 0.57 0.1000 46,666 5 46,666
2018-03-26 2016-11-22 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 7.4000 46,666 345 118,513
2018-03-26 2016-06-21 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 15,057 71,847
2018-03-26 2018-03-22 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 1.1000 181,820 200 411,105
2018-03-26 2017-09-19 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 105,015 229,285
2018-03-26 2017-06-29 4 PERRY MICHAEL S APHB Common Stock P - Purchase I 5,757 124,270
2017-12-12 2017-12-08 4 GRINT PAUL C APHB Common Stock A - Award D 0.6200 599 0 599
2017-09-12 2017-09-07 4 PERRY MICHAEL S APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-12 2017-09-07 4 SAMANT VIJAY B APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-11 2017-09-07 4 DRAPEAU LOUIS APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-11 2017-09-07 4 Johnson Wendy S. APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-09-11 2017-09-07 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 0.91 285,113 285,113
2017-09-11 2017-09-07 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 0.91 190,076 190,076
2017-09-11 2017-09-07 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 0.91 139,000 139,000
2017-09-11 2017-09-07 4 COOK JEREMY CURNOCK APHB Stock Option (Right to Buy) A - Award D 0.91 10,900 10,900
2017-06-01 2017-05-30 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0.74 87,161 87,161
2017-04-04 2017-04-01 4 Salka Michael Scott APHB Stock Option (Right to Buy) A - Award D 0.43 214,214 214,214
2017-04-04 2017-04-01 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 0.43 161,290 161,290
2017-04-04 2017-04-01 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0.43 176,411 176,411
2017-01-31 3 BILINSKY IGOR APHB Common Stock D 0
2017-01-31 2017-01-30 4 BILINSKY IGOR APHB Stock Option (Right to Buy) A - Award D 0.46 247,322 247,322
2016-12-29 2016-12-29 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0.4500 -20,077 -9 674,169
2016-12-29 2016-12-29 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0.4500 -21,923 -10 736,170
2016-12-29 2016-12-28 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0.4700 -40,450 -19 694,246
2016-12-29 2016-12-28 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0.4700 -44,170 -21 758,093
2016-12-29 2016-12-27 4 KIRK RANDAL J by Intrexon APHB Common Stock S - Sale I 0.5100 -24,092 -12 734,696
2016-12-29 2016-12-27 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock S - Sale I 0.5100 -26,308 -13 802,263
2016-12-13 2016-12-09 4 Salka Michael Scott APHB Common Stock A - Award D 0.3900 7,000 3 11,200
2016-12-13 2016-12-09 4 Martin Steven Robert APHB Common Stock A - Award D 0.3900 3,760 1 3,760
2016-11-16 2016-11-12 4 KIRK RANDAL J by NRM VII Holdings APHB Series B Preferred Stock C - Conversion I -2,142,857 0
2016-11-16 2016-11-12 4 KIRK RANDAL J by NRM VII Holdings APHB Common Stock C - Conversion I 428,571 828,571
2016-04-12 3/A COOK JEREMY CURNOCK APHB Common Stock I 120,000
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock A - Award I 4.05 35,714 35,714
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock D - Sale to Issuer I 7.00 -35,714 0
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Series B Convertible Preferred Stock C - Conversion I -1,040,753 0
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 4.05 0.0010 34,184 0 34,184
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Series B Convertible Preferred Stock P - Purchase I 0.8100 326,468 264 1,040,753
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 171,298 567,903
2016-04-12 2016-04-08 4 COOK JEREMY CURNOCK APHB Common Stock C - Conversion I 208,150 396,605
2016-04-12 2015-03-16 4 COOK JEREMY CURNOCK APHB Warrant to Purchase Common Stock P - Purchase I 10.75 10.7500 17,114 184 17,114
2016-04-12 2015-03-16 4 COOK JEREMY CURNOCK APHB Common Stock P - Purchase I 8.2500 68,455 565 188,455
2016-01-20 3 Martin Steven Robert APHB Common Stock D 0
2016-01-20 2016-01-18 4 Martin Steven Robert APHB Stock Option (Right to Buy) A - Award D 2.85 99,919 99,919
2015-11-09 2015-11-05 4 GRINT PAUL C APHB Stock Option (Right to Buy) A - Award D 5.65 16,200 16,200
2015-11-09 2015-11-05 4 SAMANT VIJAY B APHB Stock Option (Right to Buy) A - Award D 5.65 16,200 16,200
2015-10-07 2015-10-05 4 Johnson Wendy S. APHB Common Stock P - Purchase D 4.4270 1,000 4 1,000
2015-10-07 2015-10-06 4 DRAPEAU LOUIS APHB Common Stock P - Purchase D 4.3900 10,000 44 10,000
2015-10-06 2015-10-05 4 Salka Michael Scott APHB Common Stock P - Purchase D 4.7500 4,200 20 4,200
2015-09-23 2015-09-21 4 Johnson Wendy S. APHB Stock Option (right to buy) A - Award D 6.38 16,200 16,200
2015-09-23 2015-09-21 4 PERRY MICHAEL S APHB Stock Option (right to buy) A - Award D 6.38 12,800 12,800
2015-09-23 2015-09-21 4 DRAPEAU LOUIS APHB Stock Option (right to buy) A - Award D 6.38 13,800 13,800
2015-09-23 2015-09-21 4 COOK JEREMY CURNOCK APHB Stock Option (right to buy) A - Award D 6.38 38,500 38,500
2015-09-23 2015-09-21 4 Kirk Julian P. APHB Option to Purchase Common Stock A - Award D 6.38 16,200 16,200
2015-09-10 2015-09-08 4 Johnson Wendy S. APHB Stock Option (right to buy) A - Award D 7.46 49,965 49,965
2015-08-06 2015-08-05 4 Salka Michael Scott APHB Stock Option (right to buy) A - Award D 0.19 19,985,810 19,985,810
2015-03-18 2015-03-16 4 KIRK RANDAL J by Intrexon Corporation APHB Warrant to Purchase Common Stock P - Purchase I 0.22 3,484,848 3,484,848
2015-03-18 2015-03-16 4 KIRK RANDAL J by Intrexon Corporation APHB Common Stock P - Purchase I 0.1650 13,939,392 2,300 37,939,392
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68,000,000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64,000,000
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68,000,000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64,000,000
2014-02-18 3 INTREXON CORP by NRM VII Holdings APHB Common Stock I 64,000,000
2014-02-18 3 INTREXON CORP by Intrexon Corporation APHB Common Stock I 68,000,000
2014-02-18 3 PERRY MICHAEL S APHB Common Stock D 90,000
2014-02-18 3 PERRY MICHAEL S APHB Common Stock D 90,000
2014-02-18 3 COOK JEREMY CURNOCK APHB Common Stock D 130,000
2014-02-18 3 COOK JEREMY CURNOCK APHB Common Stock D 130,000
2008-11-17 3 Robinson BG Susan TGEN Common Stock D 66,915
2007-05-21 2007-05-17 4 BOWMAN JACK L TGEN Common Stock A - Award D 10,000 10,500
2007-05-21 2007-05-17 4 CARTER BARRIE J PHD TGEN Common Stock A - Award D 35,000 48,766
2007-05-21 2007-05-17 4 COOK JEREMY CURNOCK TGEN Common Stock A - Award D 15,000 15,000
2007-05-21 2007-05-17 4 DAVIE JOSEPH MD PHD TGEN Common Stock A - Award D 10,000 11,000
2007-05-21 2007-05-17 4 HAWLEY ROGER TGEN Common Stock A - Award D 10,000 10,000
2007-05-21 2007-05-17 4 LEVY NELSON L TGEN Common Stock A - Award D 10,000 10,070
2007-05-21 2007-05-17 4 PARKER H STEWART TGEN Common Stock A - Award D 50,000 81,175
2007-05-21 2007-05-17 4 PERRY MICHAEL S TGEN Common Stock A - Award D 10,000 10,000
2007-05-21 2007-05-17 4 Poston David J TGEN Common Stock A - Award D 35,000 36,700
2005-11-02 3 PERRY MICHAEL S TGEN Common Stock D 0
2005-10-04 3 Poston David J TGEN Common Stock D 17,000
2005-08-16 3 HAWLEY ROGER TGEN Np securities held D 0
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8700 -2,500 -2 11,926,948
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8600 -25,660 -22 11,929,448
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8500 -11,200 -10 11,955,108
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8300 -10,640 -9 11,966,308
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8200 -12,500 -10 11,976,948
2005-07-27 2005-07-26 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.8100 -2,500 -2 11,989,448
2005-07-27 2005-07-25 4 BIOGEN INC. by Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value S - Sale I 0.7900 -8,500 -7 11,991,948
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 851,873
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 3,060,754
2005-07-12 3 BIOGEN IDEC MA INC By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value I 508,673
2005-07-12 2003-08-15 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value P - Purchase I 1.9100 2,515,843 4,805 12,127,178
2005-07-12 2002-11-06 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value J - Other I 1.0700 -210,819 -226 9,611,335
2005-07-12 2002-09-30 4 BIOGEN INC. By Biogen Idec MA, Inc. TGEN Common Stock, $0.01 Par Value J - Other I 0.5500 104,854 58 9,400,516
2005-01-10 2005-01-06 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7500 -43,600 -76 11,626,282
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7500 -225,335 -394 11,669,882
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7600 -14,465 -25 11,895,217
2005-01-06 2005-01-05 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.8000 -10,200 -18 11,909,682
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7000 -77,919 -132 11,919,882
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7100 -1,750 -3 11,997,801
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7200 -7,591 -13 11,999,551
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7500 -24,500 -43 12,007,142
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7600 -3,800 -7 12,031,642
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7700 -20,690 -37 12,035,442
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.7800 -6,400 -11 12,056,132
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.8000 -1,400 -3 12,062,532
2005-01-06 2005-01-04 4 ELAN CORP PLC I TGEN Common Stock S - Sale I 1.8100 -950 -2 12,063,932
2004-04-02 2004-03-31 4 ELAN CORP PLC I TGEN Series B Convertible Exchangeable Preferred Stock C - Conversion I 3.32 -12,015 0
2004-04-02 2004-03-31 4 ELAN CORP PLC I TGEN Common Stock C - Conversion I 3.3200 4,330,000 14,376 12,064,882
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Series B Convertible Exchangeable Preferred Stock J - Other I 3.32 0
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.09 302,934.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.80 63,420.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.88 190,800.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.57 127,200.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.49 134,832.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.65 57,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.83 180,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.96 120,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.19 127,200.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.95 950,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.48 3,000,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3.78 2,000,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3.70 120,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 6.11 2,000,000.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.09 302,934.0000
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.4900 277,775 136 7,734,882
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.5700 221,757 126 7,457,106
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.6500 87,922 57 7,235,349
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.8300 217,549 181 7,147,427
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 0.9600 124,630 120 6,929,878
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1.1900 107,044 127 6,805,248
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1.8800 101,439 191 6,698,204
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 1.9500 487,248 950 6,596,765
2003-11-05 2003-09-02 4 ELAN CORP PLC N/A TGEN Common Stock J - Other I 2.0900 3,577,879 7,478 6,109,517
2003-11-05 2003-08-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 2.80 63,420.0000
2003-11-05 2003-06-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.88 190,800.0000
2003-11-05 2003-04-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.57 127,200.0000
2003-11-05 2003-03-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.49 134,832.0000
2003-11-05 2003-02-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.65 57,000.0000
2003-11-05 2002-12-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.83 180,000.0000
2003-11-05 2002-10-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 0.96 120,000.0000
2003-11-05 2002-09-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 1.19 127,200.0000
2003-11-05 2002-08-09 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 1.95 950,000.0000
2003-11-05 2002-06-28 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 2.48 3,000,000.0000
2003-11-05 2002-04-25 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 3.78 2,000,000.0000
2003-11-05 2002-03-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note J - Other I 3.70 120,000.0000
2003-11-05 2001-09-26 4 ELAN CORP PLC N/A TGEN Convertible Promissory Note P - Purchase I 6.11 2,000,000.0000
2003-11-05 2000-08-09 4 ELAN CORP PLC N/A TGEN Common Stock P - Purchase I 13.0640 382,739 5,000 2,531,638
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)
Other Listings
DE:TG1N €2.44
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista